NCT03852186

Brief Summary

Obsessive compulsive disorder (OCD) is one of the most disabling anxiety disorders occurring in about 2 out of a 100 adults. Untreated, OCD is a chronic and deteriorating condition, negatively impacting multiple areas of life with high personal and socioeconomic costs. In Denmark, anxiety disorders are estimated to be the most expensive of all psychiatric disorders and the most common reason for forced retirement. In many countries including DK, CBT is the recommended, first-line treatment for OCD. All individuals who seek treatment in the Danish Regions are offered CBT. However, reviews show that up to 50% of patients either do not respond to CBT or terminate treatment prematurely. Despite this large number of non-responders, no significant progress for OCD treatment has been made since initial efficacy trials. Alternatives to CBT are needed . Acceptance and Commitment therapy (ACT) is an innovative psychotherapy that can potentially help individuals with OCD who do not benefit from CBT. ACT targets the habitual thinking and behaviors that mark OCD by aiming to increase value-based behavior. OCD often co-occurs with depression and other anxiety disorders making treatment more difficult. ACT is a transdiagnostic treatment targeting symptoms that are common to anxiety and mood disorders. Preliminary findings indicate that ACT may be an effective treatment for OCD. However, these findings constitute a low level of evidence. Before ACT can be declared as an effective treatment for OCD, it needs to be demonstrated in randomize controlled trials, in which ACT is compared to legitimate, active treatments, such as CBT. This project will test the effectiveness of group-based ACT by comparing it to the first-line treatment, group-CBT in 180 participants referred for treatment in a specialized outpatient clinic at the Mental Health Services, Capital Region of Denmark. Furthermore, moderators and predictors of treatment response will be investigated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
178

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 18, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 25, 2019

Completed
5 days until next milestone

Study Start

First participant enrolled

March 2, 2019

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2023

Completed
1.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 25, 2025

Completed
Last Updated

June 29, 2025

Status Verified

February 1, 2019

Enrollment Period

4.5 years

First QC Date

February 18, 2019

Last Update Submit

June 25, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Yale Brown obsessive compulsive scale

    Semi-structured interview, total score consists of all items of all items summed up, likert scale minimum 0- maximum 4, higher values predict worse OCD-symptoms

    25 minutes

  • Quality of Life Inventory

    Self-report measure, 16 items, minimum -3 - maximum 3. Higher scores indicate higher quality of life. measuring outcome in terms of an overall life satisfaction score, likert scale 0-6

    20 minutes

Study Arms (2)

Cognitive behavioral therapy

ACTIVE COMPARATOR

Manualized group-based cognitive behavioual therapy delivered by clinical psychologists and psychiatrists. The treatment consists of 14 sessions of each 2 hours.

Behavioral: Cognitive behavioral therapy

Acceptance and commitment therapy

EXPERIMENTAL

Manualized group-based Acceptance and Commitment therapy delivered by clinical psychologists and psychiatrists. The treatment consists of 14 sessions of each 2 hours.

Behavioral: Acceptance and commitment therapy

Interventions

Group based psychotherapy

Cognitive behavioral therapy

Group based psychotherapy

Acceptance and commitment therapy

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • have OCD as their primary diagnosis
  • are between 18-65 years
  • are free of alcohol and substance abuse
  • are not receiving any other psychotherapy during the study
  • are medication-free or stabilized on psychotropic medication
  • speak and understand Danish
  • provide written consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Copenhagen

Copenhagen, 2100, Denmark

Location

MeSH Terms

Conditions

Obsessive-Compulsive Disorder

Interventions

Cognitive Behavioral TherapyAcceptance and Commitment Therapy

Condition Hierarchy (Ancestors)

Anxiety DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Assessor blinded
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Multicenter Non-inferiority Block Randomized Controlled Trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Postdoctoral Researcher

Study Record Dates

First Submitted

February 18, 2019

First Posted

February 25, 2019

Study Start

March 2, 2019

Primary Completion

August 31, 2023

Study Completion

June 25, 2025

Last Updated

June 29, 2025

Record last verified: 2019-02

Data Sharing

IPD Sharing
Will not share

Locations